Stuart has over 15 years’ experience leading the commercial exploitation of healthcare intellectual property. He has been directly responsible for commercial deals covering technology licensing, acquisitions and raising finance for new company formations.
Stuart was previously Commercialisation Director for Health Enterprise East where he had overall responsibility for the NHS innovation pipeline, project protection, commercialisation along with operational management of the Medtech Accelerator.
Prior to this, Stuart gained extensive experience with intellectual property management and commercial analysis whilst working for GlaxoSmithKline. He holds an MSc in the Management of Intellectual Property from the Queen Mary University of London, a Diploma in European Intellectual Property and a BSc in Human Biosciences.